In 2026, global equity markets have surged, largely ignoring geopolitical tensions like the U.S.-Iran war and inflation fears, with indexes such as the S&P 500 and Nasdaq reaching new highs. However, bond markets tell a different story, as government bond yields have risen sharply, reflecting concerns about inflation and interest rate hikes. This divergence has raised alarms among investors and analysts, who warn that equity markets may face a correction soon, especially if bond yields continue to climb. The situation remains uncertain, with some experts suggesting the correction could be temporary if central banks manage inflation effectively, while others caution that prolonged inflation or geopolitical risks could weigh heavily on stocks.
Goldman Sachs Group, Inc. disclosed that it briefly held a combined stake exceeding 3% in Ontex Group NV shares as of October 27, 2026, with 566,115 voting rights and 1,965,157 financial instruments. However, by October 28, 2026, their combined posit...
BNP Paribas announced its monthly declaration of voting rights and shares as of October 31, 2026. The bank reported a total of 1,101,600,607 shares and an equal number of voting rights. This update is part of regulatory compliance under French commer...
Ontex disclosed that Goldman Sachs Group, Inc. crossed the 3% ownership threshold in Ontex shares on October 27, 2026, holding a combined total of 3.07% including voting rights and financial instruments. However, the next day, October 28, 2026, Goldm...
Neion Bio has appointed John A. Maga, Ph.D., as Head of Biologics and CMC to lead the development of biologic medicines using its Raptor platform, which produces proteins in transgenic chicken eggs. Maga brings over 25 years of biopharmaceutical expe...
The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...
